FT1K:LSE:LSE-Amundi MSCI UK IMI SRI PAB UCITS ETF DR - GBP GBP (GBX)

ETF | Others |

Last Closing

USD 1160.1

Change

+8.60 (+0.75)%

Market Cap

N/A

Volume

222.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-10 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+10.18 (+3.91%)

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

+1.14 (+1.86%)

USD 292,109.19B
0R15:LSE SoftBank Group Corp.

N/A

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

N/A

USD 7,596.04B
0R1O:LSE Amazon.com Inc.

-11.50 (-6.07%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+30.10 (+2.74%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.10 (+0.72%)

USD 592.18B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.23 (+1.32%)

USD 592.18B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

+18.50 (+0.93%)

USD 330.91B

ETFs Containing FT1K:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.91% 65% D 63% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.91% 64% D 63% D
Trailing 12 Months  
Capital Gain 8.89% 45% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.89% 44% F 53% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 11.16% 75% C 75% C
Dividend Return 11.16% 74% C 75% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 257.37% 9% A- 8% B-
Risk Adjusted Return 4.34% 33% F 44% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.